RISK-WEIGHTED APOB OUTPERFORMS TRADITIONAL LIPID BIOMARKERS IN PREDICTING RESIDUAL CARDIOVASCULAR RISK IN STATIN-TREATED HYPERTRIGLYCERIDEMIC PATIENTS: POST HOC ANALYSIS OF THE REDUCE-IT PLACEBO ARM
Michaela Rehman, Elias Björnson, Deepak Bhatt, Philippe Gabriel Steg et autres
0 citations
Atherosclerosis